Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA approves first COVID-19 treatment for young children

April 26, 2022
Manufacturing and Production

The FDA has expanded the approval of the COVID-19 treatment, Veklury (remdesivir), to include pediatric patients 28 days of age …

News

Mundipharma and Cidara Therapeutics report positive Phase III results into candidemia treatment

April 26, 2022
Medical Communications

Mundipharma and Cidara Therapeutics have presented data from the Phase III ReSTORE trial of rezafungin, in the treatment of candidemia …

News

New data for Shionogi’s COVID-19 antiviral show rapid virus clearance

April 25, 2022
Sales and Marketing

Shionogi has announced new results from two late-breaking presentations of S-217622. This is an investigational 3CL protease inhibitor that was …

News

National shortage of HRT medication due to high demand

April 25, 2022
Sales and Marketing

The national shortage of HRT products could have an impact on some women, who may not be able to sleep …

News

EMA recommend new treatment option for severe postpartum haemorrhage

April 25, 2022
Sales and Marketing

Novo Nordisk has announced that the EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion …

News

Ukraine: crisis for people with chronic diseases

April 25, 2022
Sales and Marketing

Preliminary results from an ongoing nationwide health needs assessment, conducted by WHO in partnership with Premise, indicate that one in …

News

Vivesto signs agreement with CRO to evaluate anti-cancer drug formulations

April 22, 2022
Medical Communications

Vivesto AB, an oncology-focused pharmaceutical company, has announced that it is advancing research into its proprietary drug delivery formulations, and …

News

Orasis Pharmaceuticals announces positive Phase III results of eye drop candidate

April 22, 2022
Medical Communications

Orasis Pharmaceuticals has announced that the Phase III NEAR-1 and NEAR-2 clinical trials, which evaluated the efficacy and safety of …

News

FDA approves Phase III Acute Respiratory Distress Syndrome (ARDS) Trial

April 22, 2022
Medical Communications

The FDA has approved Direct Biologics to proceed with its Phase III clinical trial into the treatment of Acute Respiratory …

News

WHO “strongly recommends” Paxlovid, calls for wide distribution from Pfizer

April 22, 2022
Medical Communications

WHO has endorsed the use of Pfizer’s oral antiviral treatment for high-risk patients with mild COVID-19, following an analysis of …

News

NIHR-supported trial reveals vaccine boosters maintain immunity three months on

April 21, 2022
Business Services

Latest results form the UK’s COV-BOOST study, led by University Hospital Southampton, have shown prolonged immune responses following third doses …

News

FDA’s Cancer Advisory Committee to evaluate safety of P13K inhibitors

April 21, 2022
Business Services

The FDA’s Oncologic Drugs Advisory Committee is holding a meeting today to discuss safety findings across the entire class of …

News

PacBio and Children’s Mercy Kansas City expand collaboration in rare disease

April 21, 2022
Business Services

PacBio has announced an expanded research collaboration with Children’s Mercy Kansas City, to use the multi-omics capabilities of PacBio’s Sequel …

News

New Programme to tackle health disparities and inequalities for women with heart failure

April 21, 2022
Business Services

Women diagnosed with heart failure have worse outcomes compared to men, in spite of a similar prevalence of the chronic …

News

Takeda Nuvaxovid COVID-19 vaccine approved in Japan

April 20, 2022
Research and Development

Takeda’s Nuvaxovid Intramuscular Injection (Nuvaxovid) has been approved by the Japan Mnistry of Health, Labour and Welfare (MHLW). This is …

News

Care to Collaborate: Cydar Medical announces partnership with Medtronic

April 20, 2022
Research and Development

Cydar Medical has announced a strategic collaboration with leading healthcare technology company Medtronic. Under the pilot arrangement, Cydar’s EV Maps …

News

Study initiated for first miniaturised robotic-assisted surgery platform

April 20, 2022
Research and Development

Virtual Incision Corporation has announced the FDA approval of an Investigational Device Exemption (IDE) supplement to complete the final stage …

News

NHS Health Chief calls for return of facemasks and social distancing

April 20, 2022
Research and Development

Chris Hopson, Chief Executive of NHS Providers, which represents trusts has urged ministers to discuss “sensible precautions” for the public, …

News

AstraZeneca drug granted FDA Priority Review

April 19, 2022
Manufacturing and Production

AstraZeneca and Daiichi Sankyo have announced that the lung cancer antibody drug conjugate, Enhertu, has received Priority Review from the …

News

FDA accept New Drug Application for GSK’s daprodustat

April 19, 2022
Manufacturing and Production

GSK has announced the FDA has accepted the New Drug Application (NDA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025